Absorbable Modified Polymer (AMP™) technology is a proprietary engineering process that modifies plant starch into ultra-hydrophilic, adhesive forming hemostatic polymers. AMP™ materials are biocompatible, absorbable polysaccharides containing no animal or human components. Utilizing this purified plant source material is critical to minimizing the risks of infection and bleeding-related complications during surgery.  At SMI, patient safety is the ultimate specification.

 

AMP™ particles have a molecular structure that rapidly absorbs water from blood, creating a high concentration of platelets, red blood cells and coagulation proteins at bleeding site, which accelerates the physiologic clotting cascade.   The AMP™ on blood interaction rapidly produces a gelled matrix that adheres to and forms a mechanical barrier with the bleeding tissue.  AMP™ particles are readily dissolved by saline irrigation and are totally absorbed within several days.

 

• Safe: bioinert, plant-based source; rapid absorption within 2-3 days
• Effective: ultra-hydrophillic, hemostatic control
• Easy: off the shelf deployment with no prep
• Diversifed: technology platforms in powder, foam, film
• Customized: for open and minimally invasive applications